Human Reproduction, Vol 13, 128-131, Copyright © 1998 by Oxford University Press
J Qiao, WS Yeung, YQ Yao and PC Ho
This study compared the effects of human follicular fluid (hFF) from women
with endometriosis, tubal factor and male factor on the zona binding
capacity of human spermatozoa. Samples of hFF were collected from 30
patients, 10 patients for each of the indications of infertility, at the
time of oocyte retrieval in an in-vitro fertilization/embryo transfer
programme. The hemizona binding assay (HZA) was used to assess the effect
of these hFF on the zona binding potential of human spermatozoa. The mean
numbers of spermatozoa bound to the zona pellucida after treating the
spermatozoa with hFF from endometriosis, tubal factor and male factor were
90.5 +/- 20.9, 108.9 +/- 22.3 and 101.2 +/- 13.4 respectively. These were
significantly lower than their corresponding controls, the spermatozoa of
which were incubated with Earle's balanced salt solution (endometriosis
238.7 +/- 34.7; tubal factor 210.8 +/- 41.6; male factor 205.4 +/- 26.3; P
<0.002). The hemizona binding index (HZI) was similar between male
factor samples (52.0 +/- 6.7) and tubal factor samples (53.8 +/- 4.2).
Spermatozoa incubated with hFF from endometriosis patients (36.0 +/- 4.1)
had an HZI that was significantly lower than those treated with hFF from
tubal factor patients (P <0.01). Probably due to small sample size, the
differences in HZI between endometriosis samples and male factor samples
did not reach statistical significance (P = 0.076). These data suggest that
there was a stronger sperm-zona binding inhibitory effect of hFF from
patients with endometriosis than from those without the disease.
ARTICLES
The effects of follicular fluid from patients with different indications for IVF treatment on the binding of human spermatozoa to the zona pellucida
Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Safdarian, F. S. Mohammadi, A. Alleyassin, M. Aghahosseini, A. Meysamie, and E. Rahimi Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916) Hum. Reprod., September 1, 2007; 22(9): 2449 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jain and R. S. Gupta Trends in the Use of Intracytoplasmic Sperm Injection in the United States N. Engl. J. Med., July 19, 2007; 357(3): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mitchell, N. Rives, M. Albert, M.-C. Peers, J. Selva, B. Clavier, E. Escudier, and D. Escalier Outcome of ICSI with ejaculated spermatozoa in a series of men with distinct ultrastructural flagellar abnormalities Hum. Reprod., August 1, 2006; 21(8): 2065 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 ESHRE Capri Workshop Group Diagnosis and management of the infertile couple: missing information Hum. Reprod. Update, July 1, 2004; 10(4): 295 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.C.N. Chiu, R. Koistinen, H. Koistinen, M. Seppala, K.F. Lee, and W.S.B. Yeung Zona-Binding Inhibitory Factor-1 from Human Follicular Fluid Is an Isoform of Glycodelin Biol Reprod, July 1, 2003; 69(1): 365 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tesarik and C. Mendoza Using the Male Gamete for Assisted Reproduction: Past, Present, and Future J Androl, May 1, 2003; 24(3): 317 - 328. [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. N. Chiu, R. Koistinen, H. Koistinen, M. Seppala, K.-F. Lee, and W. S. B. Yeung Binding of Zona Binding Inhibitory Factor-1 (ZIF-1) from Human Follicular Fluid on Spermatozoa J. Biol. Chem., April 4, 2003; 278(15): 13570 - 13577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.Y.M. Tse, P.C.N. Chiu, K.F. Lee, M. Seppala, H. Koistinen, R. Koistinen, Y.Q. Yao, and W.S.B. Yeung The synthesis and fate of glycodelin in human ovary during folliculogenesis Mol. Hum. Reprod., February 1, 2002; 8(2): 142 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Luconi, F. Marra, L. Gandini, E. Filimberti, A. Lenzi, G. Forti, and E. Baldi Phosphatidylinositol 3-kinase inhibition enhances human sperm motility Hum. Reprod., September 1, 2001; 16(9): 1931 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Kutteh Antisperm antibodies: Do antisperm antibodies bound to spermatozoa alter normal reproductive function? Hum. Reprod., October 1, 1999; 14(10): 2426 - 2429. [Full Text] [PDF]
|
|